Zymergen Inc is a company in the U.S. stock market and it is a holding in 25 U.S.-traded ETFs. ZY has around 4.8M shares in the U.S. ETF market. The largest ETF holder of ZY is the ARK Genomic Revolution ETF (ARKG), with approximately 3.53M shares. Investors may also find of interest that the ETF with the largest allocation to ZY stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 0.46%. On average, U.S. ETFs allocate 0.03% of ZY to their portfolios.
Additionally, ZY is a favorite stock for Vanilla and Value ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ZY as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.